	US 12,256,740 B2
	Microorganisms for plant pathogen inhibition
Michael R. King, Oak Creek, WI (US); Sona Son, Cudahy, WI (US); Amy Lange, Greendale, WI (US); Megan Duersteler, Franklin, WI (US); and Elizabeth Galbraith, Franklin, WI (US)
Assigned to MICROBIAL DISCOVERY GROUP, LLC, Franklin, WI (US)
Filed by MICROBIAL DISCOVERY GROUP, LLC, Franklin, WI (US)
Filed on Apr. 13, 2023, as Appl. No. 18/300,126.
Application 18/300,126 is a continuation of application No. 16/585,023, filed on Sep. 27, 2019, granted, now 11,627,741.
Claims priority of provisional application 62/738,208, filed on Sep. 28, 2018.
Prior Publication US 2023/0284631 A1, Sep. 14, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 63/22 (2020.01); A01N 25/12 (2006.01); C12N 1/20 (2006.01); C12R 1/07 (2006.01)

CPC A01N 63/22 (2020.01) [A01N 25/12 (2013.01); C12N 1/20 (2013.01); C12N 1/205 (2021.05); C12R 2001/07 (2021.05)]

17 Claims

1. A commercial package comprising an isolated Bacillus strain selected from the group consisting of Bacillus strain MDGV17 (NRRL No. B-67664), Bacillus strain MDGV18 (NRRL No. B-67665), Bacillus strain MDG1607 (NRRL No. B-67666), and combinations thereof, wherein the Bacillus strain is in the form of a powder, a freeze-dried composition, a gel, or a pellet.